At the Plaza Hotel in Jung-gu, Seoul, models introduce Dongkook Pharmaceutical's summer skin care products that can be purchased at pharmacies during the summer skin care campaign held with Dongkook Pharmaceutical. /Courtesy of Yonhap News

Dongkook Pharmaceutical announced on the 9th that it conducted a 'summer skin care campaign' in Jung-gu, Seoul. During summer, sunburn, wounds, insect bites, skin barrier damage, and melasma can easily occur. The company explains that the Madecassol series is helpful for wounds, Senskin cream for sunburn and insect bites, and Senspot for acne.

Daewoong Pharmaceutical announced on the 9th that it launched the Cleident cleansing foam for dental braces. It helps with stain plaque removal, whitening, and sterilization. The sterilization power test confirmed a 99.9% sterilization effect against four types of oral bacteria. It contains patented natural-derived ingredients.

The Health Insurance Review & Assessment Service (HIRA) announced on the 9th that it started providing an information service on 'automobile insurance medical institutions.' Automobile insurance medical institutions are healthcare facilities that treat traffic accident patients under insurance and bill HIRA for medical fees. As of last year, they accounted for 28% of all medical institutions. HIRA noted, 'When a traffic accident occurs, you can easily find the medical institution that suits you.'

CHA Biotech announced on the 9th that its CHA Stem Cell Research Institute was selected as an excellent corporate-affiliated research institute and received a commendation from the Minister of Science and ICT. The company possesses approximately 80 patented technologies related to cell therapies and is developing treatments for intractable diseases such as cancer, Parkinson's disease, and aging.

Cell Biotech announced on the 9th that it has advanced its 'dual coating' technology and registered patents in five countries: Korea, Japan, China, the United States, and Europe. The technology safely delivers live probiotics to the intestines by double-coating them with proteins and polysaccharides. The company explained that it has increased the survival rate of probiotics to as high as 91.6%. This was demonstrated through human application tests showing a gut survival rate 221 times higher than that of existing uncoated probiotics.

※ This article has been translated by AI. Share your feedback here.